Please cite this article as: Y. Suzuki, M. Kiyosawa, M. Wakakura, et al., Glucose hypometabolism in the visual cortex proportional to disease severity in patients with essential blepharospasm, NeuroImage: Clinical(2018), https://doi.Journal Pre-proof J o u r n a l P r e -p r o o f Japan. Journal Pre-proof J o u r n a l P r e -p r o o f ABSTRACT Essential blepharospasm (EB) causes difficulty in eyelid opening because of involuntary movements of the orbicularis oculi muscle. Patients with EB have functional visual loss due to sustained eyelid closure. We examined cerebral glucose metabolism in 39 patients with EB (12 men and 27 women; mean age, 52.1 years) by using positron emission tomography with 18 F-fluorodeoxyglucose. Forty-eight eye open healthy
Introduction
Essential blepharospasm (EB) is a form of focal dystonia of unknown cause characterized by involuntary spasms of the musculature of the upper face. EB causes difficulty in eyelid opening because of involuntary movements of the orbicularis oculi muscle. Most patients with EB have clinical symptoms of sustained eyelid closure, and patients with severe EB cannot independently open their eyes. In our previous study using positron emission tomography (PET) and 18 F-fluorodeoxyglucose (FDG), we observed glucose hypermetabolism in the thalamus of patients with EB (Suzuki et al., 2007) and suggested that hyperactivity in the thalamus may be the cause of EB. Patients with EB have been known to have functional visual loss, and many patients have various difficulties in their life (Egan et al., 2015; Pula, 2012) . However, no study has examined the influence of the interruption of visual inputs on the visual cortex of patients with EB. In the current study, we hypothesized that the activity in the visual cortex of patients with EB decreases because of the interruption of visual inputs; therefore, we studied regional cerebral J o u r n a l P r e -p r o o f
We studied 39 patients with EB (12 men and 27 women; mean age, 52.1 years). Each patient had bilateral blepharospasm, and the degree of blepharospasm was equal in the right and left eyelids. The duration of disease was 4.9 ± 5.0 years. The control subjects were 96 healthy volunteers (33 men and 63 women; mean age, 55.5 years). None of the participants had other neurologist-diagnosed neuro-psychiatric diseases or a family history of dystonic disorders. Neither the control subjects nor the patients with EB had taken any neuro-psychiatric drugs. The control subjects divided into two groups (eye open control group (48 subjects) and eye close control group (48 subjects) so that the sex ratio and the mean age were almost equal. We instructed the eye open control group and patients with EB to open their eyelids from FDG injection to PET scanning. On the other hand, we instructed the eye close control group to close their eyelids from FDG injection to PET scanning.
Informed consent was obtained from each subject before study participation, and the J o u r n a l P r e -p r o o f in accordance with the Jankovic Rating Scale (JRS) (Jankovic and Orman, 1987) in each patient just before the PET examination. The average blepharospasm severity and frequency were 2.85 and 2.69, respectively. We hypothesized that the glucose metabolism level may be related to the strength (severity + frequency), i.e., the JRS sum score (Roggenkämper et al., 2006) . We surmised that visual input during the period from FDG injection to PET scan is reflected in glucose metabolism in the visual cortex.
Among our patients, 19 with EB were conscious of photophobia that patients with blepharospasm frequently experienced dazzling or eye pain (Hallett, 2002) .
2.2.Magnetic resonance imaging
Magnetic resonance imaging (MRI) scans were performed on each subject to screen for organic brain disorders by using a 1.5-T Signa Horizon scanner (General Electric, Milwaukee, WI). Trans-axial images with T1-weighted contrast (3DSPGR; TR = 9.2 ms, TE = 2.0 ms, matrix size = 256  256  124, and voxel size = 0.94  0.94  1.3 mm), and J o u r n a l P r e -p r o o f
2.3.PET data acquisition
PET scans were performed using the SET 2400W scanner (Shimadzu, Kyoto, Japan) at the Positron Medical Center, Tokyo Metropolitan Institute of Gerontology. A bolus of 2.5 MBq/kg (body weight) FDG was injected intravenously (Suzuki et al., 2007) . All subjects remained supine position on the bed in a ready room separated by white walls and curtains. The room was bright at 200 lux. Patients with EB and eye open healthy subjects were instructed to fix white and solid ceiling from FDG injection to PET scanning. A 6-min emission scan in the three-dimensional acquisition mode was initiated 45 min after the FDG injection, and 50 trans-axial images with an inter-slice interval of 3.125 mm were acquired (matrix size = 128  128  63, and voxel size = 2.0  2.0  3.125 mm) in the scanning room at a brightness of 20 lux. We monitored the subjects by using a video camera during the scans and observed no extra movements in the ir face or other body parts (Suzuki et al., 2007) . The tomographic images were reconstructed with the filtered back-projection method using a Butterworth filter (cut-off frequency, 1.25 cycles/cm; order, 2). Attenuation was corrected by performing a transmission scan by using a 68 Ga/ 68 Ge rotating source.
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2.4.Data processing and statistical analysis
The PET images were processed using the statistical parametric mapping (SPM8) software (Friston et al., 1991) which was implemented in MATLAB (MathWorks, Sherborn, MA). Statistical parametric maps combine the general linear model and theoretical Gaussian fields to make statistical inferences about regional effects. All PET images were spatially normalized to a standard template produced by the Montreal Neurological Institute using an in house template of FDG-PET images and smoothed with a Gaussian filter for 16 mm at full width and half maximum (Suzuki et al., 2007) to increase the signal-to-noise ratio before statistical processing.
After the appropriate design matrix was specified, the subject and group effects were This enabled us to test the null hypothesis that the contrast or linear mixture (subtraction) of the estimates is zero by using SPM {t}. We chose a height threshold of P < 0.05, family-wise error-corrected and excluded small areas that showed changes in cerebral glucose metabolism; the extent threshold was 150 voxels. To evaluate whether the identified changes in glucose metabolism correlated with disease severity, we performed regression analyses between glucose metabolism and the JRS sum score. We thresholded our results at P < 0.05, family-wise error-corrected for the cluster-level (Emoto et al., 2010) and small areas that showed glucose metabolism changes were excluded; the extent threshold was 150 voxels.
We also defined regions of interest (ROIs) interactively on normalized PET images by visual inspection with reference to the corresponding MR images. ROIs were placed over both sides of the posterior striate cortex, anterior striate cortex, extrastriate cortex, and thalamus, and we measured the cerebral glucose metabolism levels of each subject.
J o u r n a l P r e -p r o o f eye close controls. We observed a significant negative correlation between the JRS sum score and relative glucose metabolism level in the striate cortex of patients with EB (Table 1 and Figure 2 ).
3.2.ROI analysis
In the ROI analysis, glucose hypometabolism was observed in both sides of the posterior striate cortex (right, P = 0.01; left, P = 0.001) and both sides of the extrastriate cortex (right, P = 0.000007; left, P = 0.000006) of patients with EB compared with eye open controls but not with eye close controls (Table 2 ). No significant change was observed in both sides of the anterior striate cortex. Glucose hypermetabolism was observed in both sides of the thalamus of patients with EB compared with both eye open controls (right, P = 6.6 × 10 -12 ; left, P = 6.6 × 10 -8 ) and eye close controls (right, P = 8.4 × 10 -10 ; left, P = 7.1 × 10 -7 ) ( Table 2) .
We observed a significant negative correlation between the JRS sum score and relative glucose metabolism level in the posterior (right: r = -0.53, P = 0.0005; left: r = -0.65, P = 0.00001) and anterior (right: r = -0.33, P = 0.04; left: r = -0.37, P = 0.02) striate cortices of patients with EB; however, no significant correlation was observed between the JRS sum score and relative glucose metabolism level in the extrastriate cortex (right: r = -0.23, P = 0.26; left: r = -0.28, P = 0.14) (Figure 3) . We also observed a significant Journal Pre-proof J o u r n a l P r e -p r o o f positive correlation between the JRS sum score and relative glucose metabolism level in the thalamus (right: r = -0.37, P = 0.02; left: r = -0.42, P = 0.008) of patients with EB ( Figure 3 ). No significant correlation was observed between the JRS sum score and cerebral glucose metabolism level in the right or left thalamus. In contrast, relative glucose metabolism level in both sides of the thalamus was higher in patients with photophobia than in patients without photophobia (Table 3) .
Discussion

Cerebral glucose metabolism in the visual cortex of patients with EB
We observed glucose hypometabolism in both sides of the posterior striate cortex and , 1991) , and these areas are activated by visual stimuli that include specific factors, such as shape, color, and motion, respectively (Chawla et al., 1999; Suzuki et al., 2004) . However, each part is hardly activated by other types of visual stimuli (Suzuki et al., 2004) . These observations suggest that activity of the striate cortex is activated by increase in visual inputs, while activity of the extrastriate cortex is hardly dependent on the quantity of visual inputs.
The central visual field is represented at the posterior striate cortex, and the peripheral visual field corresponds to the anterior parts of the striate cortex (Horton, 2006) . We J o u r n a l P r e -p r o o f visual) information and visuomotor integration, or may be interpreted as cerebellar deficit of visuomotor and visuotactile integration. On the other hand, Baker et al. (2003) examined brain activation in patients with EB during repeated blinking using fMRI, and they observed greater activation during spontaneous and voluntary blinking in EB patients compared with healthy subjects in the anterior visual cortex. This may be related to that glucose hypometabolism in the anterior striate cortex was not observed in the present study.
4.2.Cerebral glucose metabolism in the thalamus of patients with EB
We observed glucose hypermetabolism in both sides of the thalamus of patients with EB compared with healthy subjects. The results of functional imaging studies are often interpreted using the present anatomical model of information flow in the basal ganglia-thalamo-cortical motor circuit (Poston et al., 2012; Tempel et al., 1990) . In our previous PET study, we also observed significant hypermetabolism in the thalamus (Suzuki et al., 2007) . Other studies have also shown cerebral glucose hypermetabolism in the striatum and thalamus of patients with focal dystonia including blepharospasm (Esmaeli-Gustein et al., 1999; Galardi et al., 1996) .
Regional cerebral glucose metabolism in the thalamus showed a significant positive J o u r n a l P r e -p r o o f correlation with the JRS sum score. Murai et al. (2011) examined a patient with blepharospasm who had five times higher cerebral glucose metabolism by using PET.
The severity of blepharospasm changed during observation, and the severity was positively correlated with thalamic glucose metabolism. The activity of the thalamus may reflect the severity of blepharospasm.
4.3.Photophobia in patients with EB
The neuro-physiological cause of photophobia is not fully understood; however, studies have reported that light sensitivity thresholds in patients with blepharospasm are significantly lower than those in normal individuals (Adams et al., 2006) . Emoto et al.
(2010) also reported higher glucose hypermetabolism in the thalamus of patients with EB and photophobia than in patients with EB without photophobia by using PET. Recently, several "photophobia circuits" have been suggested in order to explain the pathology of photophobia (Digre et al., 2012) , and the thalamus is involved in these circuits (Noseda et al., 2010; Okamoto et al., 2009 ). It has been proposed that the thalamus is engaged in multisensory integration, and that the thalamus is a state-and gain-setting region in the brain. Studies have also reported that both the gain and precision of sensory signals are altered in the thalamus (Hirata et al., 2006) . These observations, suggested that the Journal Pre-proof J o u r n a l P r e -p r o o f thalamus may be activated by increased sensory inputs and processing of sensory signals in patients with photophobia.
Conclusion
Glucose hypometabolism was observed in both sides of the posterior striate cortex and extrastriate cortex in patients with EB. We observed a significant correlation between the JRS sum score and relative glucose metabolism level in the posterior and anterior striate cortices of patients with EB. It is surmised that interruption of the visual input is decreasing activity in the visual cortex in patients with EB. 
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